GENETRON HOLDINGS LTD-ADR (GTH) Stock Price, Quote, News and Overview
NASDAQ:GTH - Nasdaq - US37186H2094 - ADR - Currency: USD
GTH Quote, Performance and Key Statistics
4.025
+0.01 (+0.12%)
The current stock price of GTH is 4.025 USD. In the past month the price increased by 2.68%. In the past year, price increased by 27.78%.
GTH Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About GTH
Company Profile
Genetron Holdings Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Beijing, Beijing and currently employs 799 full-time employees. The company went IPO on 2020-06-19. Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The firm has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The firm operates its businesses primarily within the China market.
Company Info
GENETRON HOLDINGS LTD-ADR
1-2/F, Building 11, Zone 1, No.8 Life Science Parkway, Changping District
Beijing BEIJING 102206 CN
CEO: Sizhen Wang
Employees: 799
Company Website: https://www.genetronhealth.com
Phone: 861050907500
GENETRON HOLDINGS LTD-ADR / GTH FAQ
What is the stock price of GENETRON HOLDINGS LTD-ADR today?
The current stock price of GTH is 4.025 USD. The price increased by 0.12% in the last trading session.
What is the ticker symbol for GENETRON HOLDINGS LTD-ADR stock?
The exchange symbol of GENETRON HOLDINGS LTD-ADR is GTH and it is listed on the Nasdaq exchange.
On which exchange is GTH stock listed?
GTH stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for GENETRON HOLDINGS LTD-ADR stock?
5 analysts have analysed GTH and the average price target is 1.39 USD. This implies a price decrease of -65.54% is expected in the next year compared to the current price of 4.025. Check the GENETRON HOLDINGS LTD-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is GENETRON HOLDINGS LTD-ADR worth?
GENETRON HOLDINGS LTD-ADR (GTH) has a market capitalization of 127.29M USD. This makes GTH a Micro Cap stock.
How many employees does GENETRON HOLDINGS LTD-ADR have?
GENETRON HOLDINGS LTD-ADR (GTH) currently has 799 employees.
What are the support and resistance levels for GENETRON HOLDINGS LTD-ADR (GTH) stock?
GENETRON HOLDINGS LTD-ADR (GTH) has a support level at 3.96 and a resistance level at 4.04. Check the full technical report for a detailed analysis of GTH support and resistance levels.
Is GENETRON HOLDINGS LTD-ADR (GTH) expected to grow?
The Revenue of GENETRON HOLDINGS LTD-ADR (GTH) is expected to grow by 25.16% in the next year. Check the estimates tab for more information on the GTH EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy GENETRON HOLDINGS LTD-ADR (GTH) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GTH, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GTH, evaluating the profitability, health, valuation and growth aspects
- GENETRON HOLDINGS LTD-ADR (GTH) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- GENETRON HOLDINGS LTD-ADR (GTH) Sales and EPS estimates to see what analysts future expectations are.
- GENETRON HOLDINGS LTD-ADR (GTH) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- GENETRON HOLDINGS LTD-ADR (GTH) Insider and Institutional Ownership to learn about the owners and their transactions.
- GENETRON HOLDINGS LTD-ADR (GTH) Stock Chart to make your own analysis
- GENETRON HOLDINGS LTD-ADR (GTH) Latest news and press-releases to stay up to date.
Does GENETRON HOLDINGS LTD-ADR (GTH) stock pay dividends?
GTH does not pay a dividend.
What is the Price/Earnings (PE) ratio of GENETRON HOLDINGS LTD-ADR (GTH)?
GENETRON HOLDINGS LTD-ADR (GTH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.54).
GTH Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to GTH. When comparing the yearly performance of all stocks, GTH is one of the better performing stocks in the market, outperforming 76.99% of all stocks.
GTH Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to GTH. GTH has a bad profitability rating. Also its financial health evaluation is rather negative.
GTH Financial Highlights
Over the last trailing twelve months GTH reported a non-GAAP Earnings per Share(EPS) of -3.54. The EPS decreased by -61.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -82.89% | ||
| ROE | -148.03% | ||
| Debt/Equity | 0.05 |
GTH Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to GTH. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of 20.69% and a revenue growth 25.16% for GTH